Catalyst Wire Dossier Catalyst Wire Dossier

SNSP113

· Synspira, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SNSP113, covering 2018-05-25 to 2018-05-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis [Phase 1]

See pricing